Today, on 28 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2016 to “Nasdaq Riga”. Non-audited financial results indicate that in 2016...
JSC Tallinn Pharmaceutical Plant (Estonia) and HBM Pharma (Slovakia) have received Russian Good Manufacturing practice (GMP) certificates. Quality director of JSC Grindeks, Dr.chem. Juris Hmeļņickis...
On 20 January 2017, Central Finance and Contracting Agency (CFCA) of Republic of Latvia concluded an agreement with JSC Grindeks on the project implementation funded...
In the beginning of December in Moscow, Russia, one of the most prestigious events of pharmaceutical industry took place – Russian Pharma Awards 2016. Within...
Referring to the information published in Latvian media, which states that JSC Grindeks plans to move its manufacturing outside Latvia, we explain that the company’s...
Today, on 25 November, the JSC Grindeks submitted the non-audited consolidated financial statements for the first nine months of 2016 to “Nasdaq Riga”. Non-audited financial...
The State JSC “Privatisation Agency” is organizing a webinar scheduled on 2 November 2016 at 16:00(EEST). Please note that attendees have to register for the...
